CI
CX Institutional Portfolio holdings
AUM
$2.87B
1-Year Return
12.62%
This Quarter Return
+6.99%
1 Year Return
+12.62%
3 Year Return
+44.81%
5 Year Return
+67.11%
10 Year Return
–
AUM
$2.07B
AUM Growth
+$204M
(+11%)
Cap. Flow
+$98M
Cap. Flow
% of AUM
4.72%
Top 10 Holdings %
Top 10 Hldgs %
18.95%
Holding
573
New
49
Increased
285
Reduced
198
Closed
30
Top Buys
| 1 |
iShares MSCI World ETF
URTH
|
$39.8M |
| 2 |
Schwab US Large-Cap Value ETF
SCHV
|
$12.5M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
$12.2M |
| 4 |
Vanguard Mega Cap Growth ETF
MGK
|
$12M |
| 5 |
Vanguard Growth ETF
VUG
|
$9.79M |
Top Sells
| 1 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
$19.1M |
| 2 |
iShares MSCI Netherlands ETF
EWN
|
$15.8M |
| 3 |
iShares MSCI Denmark ETF
EDEN
|
$15.4M |
| 4 |
VanEck Gold Miners ETF
GDX
|
$15.1M |
| 5 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
$13.8M |
Sector Composition
| 1 | Technology | 7.64% |
| 2 | Healthcare | 5.49% |
| 3 | Consumer Discretionary | 4.56% |
| 4 | Industrials | 4.4% |
| 5 | Financials | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $696K | 0.03% |
13,870
+2,161
| +18% | +$108K |
|
327
Thermo Fisher Scientific
TMO
$186B
| $694K | 0.03% |
1,194
+17
| +1% | +$9.88K |
|
328
Vertex Pharmaceuticals
VRTX
$102B
| $687K | 0.03% |
1,643
-37
| -2% | -$15.5K |
|
329
Chubb
CB
$111B
| $682K | 0.03% |
2,630
-4
| -0.2% | -$1.04K |
|
330
AT&T
T
$212B
| $680K | 0.03% |
38,656
+2,590
| +7% | +$45.6K |
|
331
FedEx
FDX
$53.7B
| $679K | 0.03% |
2,342
+72
| +3% | +$20.9K |
|
332
NextEra Energy, Inc.
NEE
$146B
| $676K | 0.03% |
10,571
-525
| -5% | -$33.6K |
|
333
Glacier Bancorp
GBCI
$5.88B
| $666K | 0.03% |
16,530
| – | – |
|
334
Charles Schwab
SCHW
$167B
| $661K | 0.03% |
9,139
-264
| -3% | -$19.1K |
|
335
NXP Semiconductors
NXPI
$57.2B
| $647K | 0.03% |
2,612
-11,669
| -82% | -$2.89M |
|
336
Philip Morris
PM
$251B
| $637K | 0.03% |
6,949
-25,237
| -78% | -$2.31M |
|
337
RTX Corp
RTX
$211B
| $636K | 0.03% |
6,521
+1,841
| +39% | +$180K |
|
338
Berkshire Hathaway Class A
BRK.A
$1.08T
| $634K | 0.03% |
+1
| New | +$634K |
|
339
Nike
NKE
$109B
| $624K | 0.03% |
6,640
-319
| -5% | -$30K |
|
340
D.R. Horton
DHI
$54.2B
| $618K | 0.03% |
3,758
+235
| +7% | +$38.7K |
|
341
HCA Healthcare
HCA
$98.5B
| $616K | 0.03% |
1,848
-34
| -2% | -$11.3K |
|
342
Boston Scientific
BSX
$159B
| $600K | 0.03% |
8,767
-191
| -2% | -$13.1K |
|
343
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $600K | 0.03% |
14,370
+185
| +1% | +$7.73K |
|
344
AutoZone
AZO
$70.6B
| $596K | 0.03% |
189
+48
| +34% | +$151K |
|
345
Illinois Tool Works
ITW
$77.6B
| $595K | 0.03% |
2,217
-9,637
| -81% | -$2.59M |
|
346
Fidelity MSCI Utilities Index ETF
FUTY
$1.93B
| $591K | 0.03% |
13,921
-6,531
| -32% | -$277K |
|
347
Norfolk Southern
NSC
$62.3B
| $591K | 0.03% |
2,317
-12,965
| -85% | -$3.3M |
|
348
Morgan Stanley
MS
$236B
| $583K | 0.03% |
6,191
+71
| +1% | +$6.69K |
|
349
Medtronic
MDT
$119B
| $583K | 0.03% |
6,686
+208
| +3% | +$18.1K |
|
350
iShares US Healthcare ETF
IYH
$2.77B
| $580K | 0.03% |
+9,370
| New | +$580K |
|